We are live on ! Find out more
VXRT

Vaxart

Delisted

VXRT was delisted on the 7th of July, 2025.

59 hedge funds and large institutions have $77.3M invested in Vaxart in 2014 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 22 increasing their positions, 8 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

567% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 3

236% more capital invested

Capital invested by funds: $23M → $77.3M (+$54.3M)

175% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 8

40% more funds holding

Funds holding: 4259 (+17)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $175K

Holders
59
Holders Change
+17
Holders Change %
+40.48%
% of All Funds
1.7%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
20
Increased
22
Reduced
8
Closed
3
Calls
Puts
$175K
Net Calls
-$175K
Net Calls Change
-$70K

VXRT Hedge Fund Activity: Q1 2014 in Review

59 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q1 2014, worth a combined $77.3M — up 236% from $23M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new VXRT positions and 3 closed out — a net gain of 17 holders — while 22 added to existing stakes and 8 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $13.9M. The largest seller was 683 Capital Management, cutting an estimated $1.56M.

  • 59 institutional investors held Vaxart (VXRT) as of Q1 2014, up from 42 in Q4 2013.
  • Funds reported $77.3M of Vaxart stock for Q1 2014, up 236% quarter-over-quarter.
  • 20 funds opened new Vaxart positions in Q1 2014 and 3 closed out, a net change of +17 holders.
  • The largest Vaxart buyer in Q1 2014 was JP Morgan Chase, an estimated $13.9M added.
  • The largest Vaxart seller in Q1 2014 was 683 Capital Management, an estimated $1.56M sold.

Based on aggregated 13F filings for Q1 2014.